Search Results - "Pulmonary pharmacology & therapeutics"
-
1
Lung cancer in patients with idiopathic pulmonary fibrosis
Published in Pulmonary pharmacology & therapeutics (01-08-2017)“…Abstract Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic lung disease of unknown etiology. With a gradually increasing worldwide prevalence and a…”
Get full text
Journal Article -
2
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients
Published in Pulmonary pharmacology & therapeutics (01-08-2020)“…The COVID-19 pandemic due to SARS-CoV-2 infection can produce Acute Respiratory Distress Syndrome as a result of a pulmonary cytokine storm. Antihistamines are…”
Get full text
Journal Article -
3
The immunomodulatory effects of macrolide antibiotics in respiratory disease
Published in Pulmonary pharmacology & therapeutics (01-12-2021)“…Macrolide antibiotics are well known for their antibacterial properties, but extensive research in the context of inflammatory lung disease has revealed that…”
Get full text
Journal Article -
4
Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects
Published in Pulmonary pharmacology & therapeutics (01-04-2021)“…Coronavirus virus disease 2019 (COVID-19) is a viral infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), actually…”
Get full text
Journal Article -
5
Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway
Published in Pulmonary pharmacology & therapeutics (01-12-2020)“…Although myricetin exerts anti-inflammation, anti-cancer, and anti-oxidation effects, the relationship between myricetin and tumor necrosis factor alpha…”
Get full text
Journal Article -
6
Use of animal models in IPF research
Published in Pulmonary pharmacology & therapeutics (01-08-2018)“…Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease with a poor prognosis and limited treatment options. Many compounds have shown…”
Get full text
Journal Article -
7
BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration
Published in Pulmonary pharmacology & therapeutics (01-06-2019)“…BLU-5937 is a small molecule that was shown to be a potent, selective and non-competitive P2X3 homotrimeric receptor antagonist. P2X3 receptors are ATP…”
Get full text
Journal Article -
8
Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils
Published in Pulmonary pharmacology & therapeutics (01-04-2017)“…Abstract Introduction Asthma with adult onset and elevated blood eosinophils is a difficult-to-treat subgroup. This post hoc analysis evaluated reslizumab, an…”
Get full text
Journal Article -
9
One year of mepolizumab. Efficacy and safety in real-life in Italy
Published in Pulmonary pharmacology & therapeutics (01-10-2019)“…Severe asthma is a disease with a heavy socio-economic burden and a relevant impact on the life of patients. Mepolizumab (MEP) was recently introduced in…”
Get full text
Journal Article -
10
Pirfenidone, nintedanib and N -acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Published in Pulmonary pharmacology & therapeutics (01-10-2016)“…Abstract Background The prevalence of idiopathic pulmonary fibrosis (IPF) is increasing every year. Pirfenidone and nintedanib were approved for treatment of…”
Get full text
Journal Article -
11
Randomized controlled trials and real life studies. Approaches and methodologies: a clinical point of view
Published in Pulmonary pharmacology & therapeutics (01-04-2014)“…Abstract Randomized Controlled Trials (RCTs) are the “gold standard” for evaluating treatment outcomes providing information on treatments “efficacy”. They are…”
Get full text
Journal Article -
12
Antihistamines and azithromycin as a treatment for COVID-19 on primary health care – A retrospective observational study in elderly patients
Published in Pulmonary pharmacology & therapeutics (01-04-2021)“…Between March and April 2020, 84 elderly patients with suspected COVID-19 living in two nursing homes of Yepes, Toledo (Spain) were treated early with…”
Get full text
Journal Article -
13
Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis
Published in Pulmonary pharmacology & therapeutics (01-04-2019)“…Vitamin D (VitD) is a steroid hormone with cytoprotective and anti-inflammatory properties. Epidemiological studies have suggested a link between VitD…”
Get full text
Journal Article -
14
Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: A network approach
Published in Pulmonary pharmacology & therapeutics (01-12-2015)“…Abstract Pulmonary arterial hypertension (PAH) is responsible for the premature death mainly because of progressive and severe heart failure. This disease is…”
Get full text
Journal Article -
15
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life
Published in Pulmonary pharmacology & therapeutics (01-04-2020)“…Mepolizumab (MEP) has been recently introduced to treat severe eosinophilic asthma. Trials have demonstrated a significant effectiveness in this asthma…”
Get full text
Journal Article -
16
Cough and airway disease: The role of ion channels
Published in Pulmonary pharmacology & therapeutics (01-12-2017)“…Cough is the most common reason for patients to visit a primary care physician, yet it remains an unmet medical need. It can be idiopathic in nature but can…”
Get full text
Journal Article -
17
The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination
Published in Pulmonary pharmacology & therapeutics (01-08-2021)“…Studies with Cannabis Sativa plant extracts and endogenous agonists of cannabinoid receptors have demonstrated anti-inflammatory, bronchodilator, and…”
Get full text
Journal Article -
18
Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation
Published in Pulmonary pharmacology & therapeutics (01-10-2019)“…While effective treatments for acute respiratory distress syndrome (ARDS) are lacking, mechanical lung ventilation can sustain adequate gas exchange in…”
Get full text
Journal Article -
19
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma
Published in Pulmonary pharmacology & therapeutics (01-08-2016)“…Abstract Background There is an unmet medical need for allergic asthma patients who are uncontrolled on conventional therapies. The aim of this study was to…”
Get full text
Journal Article -
20
Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19
Published in Pulmonary pharmacology & therapeutics (01-08-2021)“…Cytokine release syndrome is a dangerous complication of the coronavirus disease 2019 (COVID-19). This study aimed to evaluate the efficacy and safety of…”
Get full text
Journal Article